Antitrust

Commission approves the acquisition of up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited by Berhyanda Limited

Commission approves the acquisition of up to 76.10% of the voting share capital of Suven
Pharmaceuticals Limited by Berhyanda Limited

Date 20/04/2023
 
Press Release (157.63 KB)